Page 2 - Market Commitment News Today

The world’s poorest countries remain the most vulnerable to climate change.

Given the sufficient supply of COVID-19 vaccines globally, Moderna & Gavi have mutually agreed to cancel remaining pending orders under the current COVID-19 vaccine supply agreement for 2022Gavi and Moderna

September saw good progress in history’s largest vaccine rollout, with COVID-19 vaccine coverage continuing to increase in lower-income countries and civil society finding its voice. Managing Director of the COVAX Facility, Dr Derrick Sim, gives his verdict.

With 1.7 billion doses delivered to more than 140 countries and territories, COVAX is the largest, most complex vaccine rollout in history. The innovations made along the way could play an important role in fighting the next pandemic.

On Friday, August 26th, Moderna Tx, Inc. and Moderna US, Inc. filed a complaint for patent infringement in Federal district court for the District of Massachusetts against Pfizer, Inc.,...

Here’s the first of a series of monthly round-ups giving a status update on the historic effort to ensure equitable uptake of COVID-19 vaccines across the world.

Pfizer and BioNTech plan to aggressively defend against Moderna's claims of patent infringement.

Moderna yesterday filed patent infringement lawsuits against Pfizer and BioNTech, alleging the two companies copied Moderna’s patented mRNA ...

Moderna and Pfizers mRNA Covid-19 vaccines have been the backbone of the US vaccination strategy, with Pfizer making up the majority of administered doses.

Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty® unlawfully infringes patents Moderna filed between 2010 and 2016Moderna not seeking